Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol
NCT: NCT05255744 · TERMINATED
Brief Summary
Each Whitsunday mask or AirFit N30i Quiet mask is worn for 7 nights. The overall purpose of this study is to evaluate the performance of the Whitsundays nasal mask system (a prototype mask) compared to the ResMed AirFit N30i Quiet mask system (a benchmark mask) in relation to seal, comfort, usability, overall performance, and efficacy.
Frequently Asked Questions
What is Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol?
Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol is a clinical trial registered under NCT05255744. Current status: TERMINATED.
What is the status of NCT05255744?
The current status of NCT05255744 (Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol) is: TERMINATED.
When did Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol start?
Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol started on 2025-03-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.